Navigation Links
Cancer Expert Dr. Eric Rowinsky to Oversee Oncology Product Development at RRD International
Date:2/17/2010

cal and clinical research fields.  

He received the career development award of the American Cancer Society and the 6th Annual Emil J. Freireich Award for outstanding achievement of a young researcher in clinical cancer therapeutics. He has also served on the Board of Scientific Counselors of the National Cancer Institute (NCI).

About RRD International

Founded in 2002, RRD is a strategy-driven product development company.  The Company's development model enables rapid proof-of-concept for biotech and pharmaceutical clients to accelerate value inflection points; reduce costs; and mitigate development as well as execution risk.  RRD offers two distinct types of client engagements:  TacDev® and DevCo®.  The TacDev® model adds development bandwidth and expertise for defined products in companies with minimal infrastructure.  The DevCo® model creates external product development companies where investment is in asset optimization rather than traditional infrastructure.  For more information visit:  www.rrdintl.com.  RRD International: Accelerating the Right Development; Creating Lasting Value.

SOURCE RRD International

RELATED LINKS
http://www.rrdintl.com/

'/>"/>

SOURCE RRD International
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
4. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
5. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
6. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
7. Novel Technology Breaks Through Cancer Pain
8. CEL-SCI Secures Manufacturing Facility for Multikine Cancer Drug
9. Furamidine Found to Inhibit a Key Enzyme Involved in Cancer Cell DNA Repair Mechanisms
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... , May 23, 2013 Israel ... Israel 2013 , Israel,s 1 st ... October 14 th -15 th in Tel ... most innovative city in the world by the Wall ... BrainTech Israel 2013 will showcase the latest breakthroughs ...
(Date:5/23/2013)... 2013 Halozyme Therapeutics, Inc. (NASDAQ: ... David A. Ramsay as ... Vice President, Corporate Development at Halozyme. ... his established financial management experience and his recent ... our commercial group for the last four years, ...
(Date:5/23/2013)... May 23, 2013  Omeros Corporation (NASDAQ: ... New Drug Application (IND) to evaluate OMS824 in ... Food and Drug Administration (FDA). OMS824 selectively inhibits ... of the brain linked to a wide range ... and schizophrenia. OMS824 has shown promising results in ...
Breaking Medicine Technology:Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference 2Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference 3Halozyme Therapeutics Names David A. Ramsay Chief Financial Officer 2Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 2Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 3Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 4
... Nov. 14, 2011 Regado Biosciences, Inc., a privately ... with active control agents, announces one poster presentation ... Association (AHA) Scientific Sessions meeting on November 14, ... EST session.  All three presentations highlight results from ...
... Corporation ("the Company"), a leading international manufacturer, marketer, and ... today announced its 2011 third quarter financial results. ... For the third quarter of 2011, the ... of 7.8% versus net sales of $223.7 million in ...
Cached Medicine Technology:Regado Biosciences, Inc. Presents Three Abstracts Pertaining to its Pipeline of Reversible Antithrombotic Agents, Including the Substudy Analyses of its Phase 2b RADAR Trial for REG1, its Lead Product Candidate, at the American Heart Association (AH 2Regado Biosciences, Inc. Presents Three Abstracts Pertaining to its Pipeline of Reversible Antithrombotic Agents, Including the Substudy Analyses of its Phase 2b RADAR Trial for REG1, its Lead Product Candidate, at the American Heart Association (AH 3Regado Biosciences, Inc. Presents Three Abstracts Pertaining to its Pipeline of Reversible Antithrombotic Agents, Including the Substudy Analyses of its Phase 2b RADAR Trial for REG1, its Lead Product Candidate, at the American Heart Association (AH 4Pregis Announces Third Quarter 2011 Financial Results 2Pregis Announces Third Quarter 2011 Financial Results 3Pregis Announces Third Quarter 2011 Financial Results 4Pregis Announces Third Quarter 2011 Financial Results 5Pregis Announces Third Quarter 2011 Financial Results 6Pregis Announces Third Quarter 2011 Financial Results 7Pregis Announces Third Quarter 2011 Financial Results 8Pregis Announces Third Quarter 2011 Financial Results 9Pregis Announces Third Quarter 2011 Financial Results 10Pregis Announces Third Quarter 2011 Financial Results 11Pregis Announces Third Quarter 2011 Financial Results 12
(Date:5/23/2013)... This news release is available in French . ... Montreal researchers have discovered a novel molecular mechanism that ... other diseases of abnormal growth. In the May 23 ... from the University of Montreal explain how they found ... or prevents cells from dividing. , "Cells normally monitor ...
(Date:5/23/2013)... Six innovative research projects have been awarded grants ... the nation's largest private nonprofit funder of Lyme disease medical ... epidemiology of, and treatment and cure for Lyme and ... support the innovative research being conducted by some of ... the field today,” said Harriet Kotsoris, MD, LRA’s Chief ...
(Date:5/23/2013)... CT (PRWEB) May 23, 2013 Applied ... solutions, announced today that it has added support for ... IDE, the eiConsole for Healthcare. In addition to ... such as LLP, FTP, and Web Services, it now ... The Direct Protocol is a specification of the ...
(Date:5/23/2013)... During pregnancy both the health of ... medical treatments, especially medication. In July 2006, a ... prompted the FDA to warn about a potential link ... as persistent pulmonary hypertension and other malformations (i). ... (SSRI) drugs. SSRI antidepressants are widely prescribed to ...
(Date:5/23/2013)... Each month Dwell magazine is filled ... and electric cars. Nowhere in America are these pages more ... car capital. Thankfully this June, Green Car Journal is bringing ... to Dwell on Design 2013 ( http://www.dwellondesign.com ), ... two days of Dwell on Design, June 21-22, attendees and ...
Breaking Medicine News(10 mins):Health News:Scientists discover how rapamycin slows cell growth 2Health News:Six Investigators Awarded Lyme Research Alliance Grants 2Health News:Six Investigators Awarded Lyme Research Alliance Grants 3Health News:Six Investigators Awarded Lyme Research Alliance Grants 4Health News:PilotFish Expand’s Healthcare Integration Capabilities with Support for the New Direct Protocol in Its Latest Product Release 2Health News:Personal Injury Law Firm Releases Graphic with the Latest Information on Antidepressants and a Possible Risk of Birth Defects 2Health News:Personal Injury Law Firm Releases Graphic with the Latest Information on Antidepressants and a Possible Risk of Birth Defects 3Health News:Dwell Media and Green Car Journal Put You in the Driver Seat At Dwell on Design 2013 2Health News:Dwell Media and Green Car Journal Put You in the Driver Seat At Dwell on Design 2013 3Health News:Dwell Media and Green Car Journal Put You in the Driver Seat At Dwell on Design 2013 4Health News:Dwell Media and Green Car Journal Put You in the Driver Seat At Dwell on Design 2013 5
... ,Time is Brain, SEATTLE, Nov. 14 On ... to activate an advanced telemedicine system,in the emergency rooms ... real-time, 24/7 link between ER physicians and stroke specialists ... Stroke,Program is based. The Swedish TeleStroke Program is ...
... Pa., Nov. 14 Escalon Medical Corp.,(Nasdaq: ESMC ... ended,September 30, 2007. For the first quarter of ... 4% decrease from the $7,168,160, reported in the prior,year ... at the,Company,s Sonomed and Vascular business units, which decreased ...
... Passion for Healthcare, MIAMI, Nov. 14 ... healthcare providers funded by,MTS Health Investors and Oaktree ... E. Burke III to the position of President ... experience to Novis,Pharmaceuticals, with extensive functional expertise in ...
... for November 20, NAPA, Calif., Nov. 14 ... company engaged in the,study of senescense, the science of ... today announced financial results for the,quarter ended September 30, ... $469,000 compared to,$2,027,000 for the same period in the ...
... - Now Families Can Breathe Easier During Cold and ... Nature,s Baby Organics,manufacturers of the finest and purest natural ... Ah-Choo! Chest Rub. Ah-Choo! Chest Rub was,created to bring ... common cold viruses and influenza. "With the unavoidable ...
... NEW YORK, NY November 14, 2007 The ... announced today that they are joining together to create ... of research into drugs and therapies to cure diabetes ... can measure the progress of disease and the effectiveness ...
Cached Medicine News:Health News:Lifesaving TeleStroke Technology Linked to Swedish 2Health News:Lifesaving TeleStroke Technology Linked to Swedish 3Health News:Lifesaving TeleStroke Technology Linked to Swedish 4Health News:Lifesaving TeleStroke Technology Linked to Swedish 5Health News:Escalon(R) Reports First Quarter Fiscal 2008 Results 2Health News:Escalon(R) Reports First Quarter Fiscal 2008 Results 3Health News:Escalon(R) Reports First Quarter Fiscal 2008 Results 4Health News:Escalon(R) Reports First Quarter Fiscal 2008 Results 5Health News:Escalon(R) Reports First Quarter Fiscal 2008 Results 6Health News:Escalon(R) Reports First Quarter Fiscal 2008 Results 7Health News:Novis Pharmaceuticals Announces Hiring of Thomas E. Burke III as President and CEO 2Health News:Novis Pharmaceuticals Announces Hiring of Thomas E. Burke III as President and CEO 3Health News:Senetek PLC Reports Third Quarter 2007 Financial Results 2Health News:Senetek PLC Reports Third Quarter 2007 Financial Results 3Health News:JDRF and Lilly partner to fund research to identify beta cell biomarkers 2Health News:JDRF and Lilly partner to fund research to identify beta cell biomarkers 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: